Cytek Biosciences (CTKB) Current Assets (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Current Assets came in at $379.3 million in Q1 2026, little changed YoY from $380.5 million in Q1 2025, and down 3.24% on a QoQ basis from $392.0 million in Q4 2025.
Cytek Biosciences (CTKB) Current Assets (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Current Assets data on file, last reported at $379.3 million in Q1 2026.
- Quarterly Current Assets changed 0.32% year-over-year to $379.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $379.3 million (changed 0.32% YoY) and the FY2025 annual result came in at $392.0 million, down 1.12% from the prior year.
- Current Assets declined to $379.3 million in Q1 2026, from $392.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $454.0 million in Q4 2022 to a low of $379.3 million in Q1 2026.
- A 5-year average of $407.5 million and a median of $392.1 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets jumped 104.33% — and 2023, when it declined 13.65%.
- Tracing CTKB's Current Assets over 5 years: stood at $454.0 million in 2022, then retreated by 13.65% to $392.1 million in 2023, then rose by 1.12% to $396.4 million in 2024, then decreased by 1.12% to $392.0 million in 2025, then dropped by 3.24% to $379.3 million in 2026.
- The last three Current Assets figures came in at $379.3 million (Q1 2026), $392.0 million (Q4 2025), and $388.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.42 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 7.97 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.82 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 4.09 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.50 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.84 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn | 377.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 377.93 Mn |
| Mar 31, 2026 | 379.30 Mn |
| Dec 31, 2025 | 392.00 Mn |
| Sep 30, 2025 | 388.49 Mn |
| Jun 30, 2025 | 382.83 Mn |
| Mar 31, 2025 | 380.50 Mn |
| Dec 31, 2024 | 396.45 Mn |
| Sep 30, 2024 | 390.19 Mn |
| Jun 30, 2024 | 384.08 Mn |
| Mar 31, 2024 | 388.65 Mn |
| Dec 31, 2023 | 392.06 Mn |
| Sep 30, 2023 | 422.32 Mn |
| Jun 30, 2023 | 424.82 Mn |
| Mar 31, 2023 | 425.62 Mn |
| Dec 31, 2022 | 454.02 Mn |
| Sep 30, 2022 | 443.86 Mn |
| Jun 30, 2022 | 443.27 Mn |
| Mar 31, 2022 | 439.11 Mn |
| Dec 31, 2021 | 431.73 Mn |
| Sep 30, 2021 | 439.83 Mn |